The FDA has approved a dihydroergotamine-based nasal powder for the acute treatment of migraine with or without aura in ...

Adult and pediatric generalized myasthenia gravis patients have a new, longer acting option for treatment called Imaavy.

Dechra Announces FDA Approval of Otiserene® (marbofloxacin, terbinafine, and dexamethasone otic suspension) the latest ...

Satsuma Pharmaceuticals, Inc. and its corporate parent, Shin Nippon Biomedical Laboratories, Ltd, announced that the U.S.

The FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the AARP Now app. New and improved, it’s the app that makes ...

60-count bottle Propafenone hydrochloride extended-release capsules 325 mg, 60-count bottle Solifenacin succinate tablets 10 mg, 30-count bottle and 90-count bottle Voriconazole tablets 200 mg ...

The findings presented provide valuable insights into the management of MG with corticosteroid monotherapy. Credit: LightField Studios / Shutterstock. On 7 April, at the 2025 American Academy of ...

The Mumbai-based drug major, in a statement, said it has launched Fexuprazan tablets (40 mg) in India under the brand name Fexuclue, a novel potassium-competitive acid blocker (PCAB). The product is ...

The problem of Pakistan couldn't have come at a worse time for D-St The product is approved as a new treatment for adults with Erosive Esophagitis of all grades, it added. Sun Pharma has obtained ...

The drug, available in 40 mg tablets, is approved as a new treatment for adults with erosive esophagitis of all grades. FEXUCLUE, containing Fexuprazan, is primarily used to treat acid-related ...

Net advances grow 1.4% to Rs 3.47 lakh crore Vs Rs 3.43 lakh crore Deposits increase 6.8% to Rs 4.11 lakh crore Vs Rs 3.84 lakh crore The GMV (gross merchandise value) growth for beauty vertical ...